CEBP Susan G. Komen for the Cure-AACR Outstanding Investigator Award for Breast Cancer Research Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gunter, M. J.
Right arrow Articles by Rothman, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gunter, M. J.
Right arrow Articles by Rothman, N.
Cancer Epidemiology Biomarkers & Prevention Vol. 15, 1126-1131, June 2006
© 2006 American Association for Cancer Research

Inflammation-Related Gene Polymorphisms and Colorectal Adenoma

Marc J. Gunter1,2, Federico Canzian3,4, Stefano Landi3,5, Stephen J. Chanock1, Rashmi Sinha1 and Nathaniel Rothman1

1 Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, NIH, Bethesda, Maryland; 2 Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York; 3 IARC, Lyon, France; 4 German Cancer Research Center, Heidelberg, Germany; and 5 Department of Biology and Genetics, University of Pisa, Pisa, Italy

Requests for reprints: Marc Gunter, Department of Epidemiology and Population Health, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461. E-mail: mgunter{at}aecom.yu.edu

Chronic inflammation has been reported to be a risk factor for colorectal neoplasia. The propensity to mount an inflammatory response is modified by germ line variation in cytokine and other inflammation-related genes. We hypothesized that a proinflammatory genotype would be positively associated with colorectal adenoma, a precursor of colorectal cancer. We investigated the association of colorectal adenoma with 19 single nucleotide polymorphisms in a range of important proinflammatory (IL1B, IL6, IL8, TNF, and LTA) and anti-inflammatory (IL4, IL10, and IL13) cytokines and other inflammation-related genes (PTGS2 and PPARG) in a case-control study of risk factors for colorectal polyps in which all participants (ages 18-74 years) had undergone colonoscopy or sigmoidoscopy. The study sample comprised 244 cases of colorectal adenoma and 231 polyp-free controls. Compared with being homozygous for the common allele, heterozygosity at the IL1B –31 (C>T) locus was associated with an odds ratio (OR) for colorectal adenoma of 1.8 [95% confidence interval (95% CI), 1.2-2.9]. Homozygous carriers of the IL8 –251-A allele were at 2.7-fold increased risk of adenoma (95% CI, 1.5-4.9) compared with homozygosity for the common T allele, whereas carriage of at least one IL8 –251-A allele conferred a 1.5 increased odds of disease (95% CI, 1.0-2.4). Among non–nonsteroidal anti-inflammatory drug users, there was a statistically significant association between the IL10 –819-T/T genotype and adenoma compared with the common IL10 –819-C/C genotype (OR, 3.9; 95% CI, 1.1-13.6), which was not evident among nonsteroidal anti-inflammatory drug users (OR, 0.7; 95% CI, 0.3-1.5; Pinteraction = 0.01). These exploratory data provide evidence that polymorphic variation in genes that regulate inflammation could alter risk for colorectal adenoma. (Cancer Epidemiol Biomarkers Prev 2006;15(6):1126–31)




This article has been cited by other articles:


Home page
CarcinogenesisHome page
S. Wilkening, B. Tavelin, F. Canzian, K. Enquist, R. Palmqvist, A. Altieri, G. Hallmans, K. Hemminki, P. Lenner, and A. Forsti
Interleukin promoter polymorphisms and prognosis in colorectal cancer
Carcinogenesis, June 1, 2008; 29(6): 1202 - 1206.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Kim, T. O. Keku, C. Martin, J. Galanko, J. T. Woosley, J. C. Schroeder, J. A. Satia, S. Halabi, and R. S. Sandler
Circulating Levels of Inflammatory Cytokines and Risk of Colorectal Adenomas
Cancer Res., January 1, 2008; 68(1): 323 - 328.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
C. C. Reyes-Gibby, M. Spitz, X. Wu, K. Merriman, C. Etzel, E. Bruera, R. Kurzrock, and S. Shete
Cytokine Genes and Pain Severity in Lung Cancer: Exploring the Influence of TNF-{alpha}-308 G/A IL6-174G/C and IL8-251T/A
Cancer Epidemiol. Biomarkers Prev., December 1, 2007; 16(12): 2745 - 2751.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
K. L. Margolis, R. J. Rodabough, C. A. Thomson, A. M. Lopez, A. McTiernan, and for the Women's Health Initiative Research Group
Prospective Study of Leukocyte Count as a Predictor of Incident Breast, Colorectal, Endometrial, and Lung Cancer and Mortality in Postmenopausal Women
Arch Intern Med, September 24, 2007; 167(17): 1837 - 1844.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 2006 by the American Association for Cancer Research.